Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Identifying Biomarkers to Predict Resistance to Lutetium-177–PSMA-617

Featuring Oliver Sartor, MD


At the 2023 EANM meeting, Oliver Sartor, MD, Mayo Clinic, Rochester, Minnesota, discussed identifying biomarkers to predict resistance to Lutetium-177–PSMA-617 using circulating tumor DNA among patients with metastatic castration-resistant prostate cancer.

Transcript:

Transcript to come.


Source:

Sartor O. Prediction of resistance to PSMA-617 Lu-177 by assessment of circulating tumor DNA biomarkers. Presented at the 2023 European Association of Nuclear Medicine Congress; September 9-13, 2023; Vienna, Austria. OP-336.

 

© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.
 
 

Advertisement

Advertisement

Advertisement

Advertisement